Titration of β-blockers in heart failure

PREVIEW

Despite extensive data supporting the use of β-blockers in patients with chronic heart failure, fewer than one third of eligible patients receive these agents. Furthermore, some patients who do receive β-blocker therapy are given suboptimal doses. In this article, Dr Basile discusses the careful adjustment of β-blocker dose during initiation of therapy to successfully manage chronic heart failure and minimize adverse events.